首页|溶瘤病毒在膀胱癌治疗中的研究进展

溶瘤病毒在膀胱癌治疗中的研究进展

扫码查看
膀胱癌是最常见的泌尿系统恶性肿瘤之一,目前推荐以手术治疗、放化疗等多方式的综合性治疗,但总体预后较差,临床上迫切需要更有效的药物,而溶瘤病毒为此提供了新的契机.溶瘤病毒代表了一种尖端且具有潜力的癌症免疫治疗方法.它是一种能够选择性地感染和破坏肿瘤细胞的病毒,杀伤力大并且可同时避免伤害正常细胞的特点.目前溶瘤病毒对于膀胱癌的治疗尤其是在非浸润性膀胱癌方面有了重大的突破,并在多项临床试验中表达出了有效性和安全性.本文将对几种应用广泛的溶瘤病毒的种类,改造方法,抑癌机制及相关的信号表达通路在膀胱癌的研究现状和进展进行综述.
Research progress of oncolytic virus in the treatment of bladder cancer
Bladder cancer is one of the most common malignant tumors of the urinary system.Currently,surgi-cal treatment,radiotherapy and chemotherapy are recommended,but the overall prognosis is poor,and more effective drugs are urgently needed clinically.Oncolytic virus provides a new opportunity for this.Oncolytic viruses represent a cutting-edge and promising approach to cancer immunotherapy.It is a virus that can selectively infect and destroy tumor cells,killing a lot and avoiding the characteristics of harming normal cells at the same time.At present,oncolyt-ic virus has made a major breakthrough in the treatment of bladder cancer,especially in non-invasive bladder cancer,and has been shown to be effective and safe in many clinical trials.In this review,the types,modification methods,cancer inhibition mechanisms and related signal expression pathways of several widely used oncolytic viruses in bladder cancer are reviewed.

Bladder cancerOncolytic virusImmunotherapy

陈俊豪、施鸿金、王海峰、谭智勇、王龙、董昊楠、左桀明、付什

展开 >

昆明医科大学第二附属医院泌尿外科云南省泌尿外科研究所,昆明 650101

玉溪市人民医院泌尿外科,玉溪 653100

膀胱癌 溶瘤病毒 免疫疗法

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(1)
  • 55